share_log

Assessing Surmodics: Insights From 5 Financial Analysts

Benzinga ·  May 31 01:01

Surmodics (NASDAQ:SRDX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings21200
Last 30D00000
1M Ago11200
2M Ago10000
3M Ago00000

The 12-month price targets, analyzed by analysts, offer insights with an average target of $49.4, a high estimate of $71.00, and a low estimate of $43.00. Experiencing a 16.27% decline, the current average is now lower than the previous average price target of $59.00.

price target chart

Diving into Analyst Ratings: An In-Depth Exploration

The perception of Surmodics...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment